Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
3
×
ipo
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
startups
3
×
venture capital
biogen
boulder/denver blog main
boulder/denver top stories
deals
deerfield management
detroit blog main
detroit top stories
drug development
europe blog main
europe top stories
fda
gilead sciences
indiana blog main
indiana top stories
laura shawver
melinta therapeutics
national
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
What
ipo
3
×
bio
covid
medicines
plans
roundup
acquisitions
activity
advance
announced
approvals
biogen
biology
ceo
clamped
collabs
company
cytokine
daniel
deal
delays
developing
drugs
economic
enhanced
fast
fda
files
gilead
gilead’s
help
including
initial
introduce
isn’t
laying
lot
money
month
new
Language
unset
Current search:
cancer
×
startups
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs